Find a trial

TREVI-OC-01 / D8991C00001

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01)

Locations Wesley

Diagnosis Ovarian cancer

PEAK-1

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Locations Hobart, Adelaide, Wesley, Chermside

Diagnosis Kidney cancer

MTX-HER2-304

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

Locations South Brisbane

Diagnosis Advanced solid tumours

MEN2501-01

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

Locations South Brisbane

Diagnosis Advanced solid tumours

LM299-01-102

Study of LM-299 in Subjects Advanced Malignant Tumors

Locations South Brisbane

Diagnosis Advanced solid tumours

KLK2-PASenger / 78278343PCR3003

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (KLK2-PASenger)

Locations Adelaide

Diagnosis Prostate cancer